Cita APA

Lopez-Miranda, E., Perez-Garcia, J., Di Cosimo, S., Brain, E., Ravnik, M., Escriva-de-Romani, S., . . . Cortes, J. (2020). Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial.

Citación estilo Chicago

Lopez-Miranda, E., et al. Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial. 2020.

Cita MLA

Lopez-Miranda, E., et al. Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial. 2020.